These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the Patnaik MM; Pophali PA; Lasho TL; Finke CM; Horna P; Ketterling RP; Gangat N; Mangaonkar AA; Pardanani A; Tefferi A Haematologica; 2019 Jun; 104(6):e236-e239. PubMed ID: 30606787 [No Abstract] [Full Text] [Related]
11. Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors. Geissler K; Jäger E; Barna A; Alendar T; Ljubuncic E; Sliwa T; Valent P Leukemia; 2016 Nov; 30(11):2280-2281. PubMed ID: 27585952 [No Abstract] [Full Text] [Related]
12. [Xanthogranuloma, type I neurofibromatosis and myelomonocytic leukemia with spontaneous regression]. Dehen L; Zeller J; Cosnes A; Bernaudin F; Roujeau JC; Revuz J Ann Dermatol Venereol; 1990; 117(11):812-4. PubMed ID: 2129184 [No Abstract] [Full Text] [Related]
13. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia. Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005 [TBL] [Abstract][Full Text] [Related]
14. RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro. Ohtsuka Y; Manabe A; Kawasaki H; Hasegawa D; Zaike Y; Watanabe S; Tanizawa T; Nakahata T; Tsuji K Blood; 2005 Nov; 106(9):3134-41. PubMed ID: 16046524 [TBL] [Abstract][Full Text] [Related]
15. Biotinidase deficiency and juvenile myelomonocytic leukemia in a Turkish infant of consanguineous parents. Yetgin S; Aytac S; Kalkanoglu S; Coskun T; Ortmann C; Kratz C; Niemeyer C Pediatr Hematol Oncol; 2007 Sep; 24(6):453-5. PubMed ID: 17710663 [TBL] [Abstract][Full Text] [Related]
16. Juvenile myelomonocytic leukemia in a child with Crohn disease. Oliver JW; Farnsworth B; Tonk VS Cancer Genet Cytogenet; 2006 May; 167(1):70-3. PubMed ID: 16682290 [TBL] [Abstract][Full Text] [Related]
17. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia. Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice. Parikh C; Subrahmanyam R; Ren R Blood; 2006 Oct; 108(7):2349-57. PubMed ID: 16763213 [TBL] [Abstract][Full Text] [Related]
19. An evolutionary perspective on chronic myelomonocytic leukemia. Itzykson R; Solary E Leukemia; 2013 Jul; 27(7):1441-50. PubMed ID: 23558522 [TBL] [Abstract][Full Text] [Related]
20. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. Wang SA; Galili N; Cerny J; Sechman E; Chen SS; Loew J; Liu Q; Fadare O; Hasserjian R; Jones D; Qawi H; Woda B; Raza A Am J Clin Pathol; 2006 Nov; 126(5):789-97. PubMed ID: 17050076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]